Indivior Share Discussion Threads

[gregmorg] 28/10/2021 13:38

webcast finished and yes it was upbeat as you would expect from the actual results statement. Nice to see the upgraded guidance for the full year. still got a $ 1billion cash. Used $31m out of the $100m allocated for the share buy back program. So medium term this share looks as if it will keep rolling along!

[youngers] 28/10/2021 13:33

Mgmt team sounded very upbeat on the call. Great progress against all their strategic initiatives

[waldron] 28/10/2021 13:27

Michele Maatouk

Sharecast News

28 Oct, 2021 12:41

Indivior lifts FY guidance as Q3 profits, revenue jump



Indivior lifted its full-year guidance on Thursday as it reported a rise in third-quarter revenue and profit.




In the nine months to 30 September, net revenue rose 23% to $568m, while third-quarter revenues were up 18% to $187m. Indivior said this was driven mainly by its opioid addiction treatment Sublocade, continued growth in the buprenorphine medication-assisted treatment (BMAT) market, and by market share stability for Suboxone film in the US.

Sublocade net revenues grew 86% year-to-date versus 2020 and 97% versus the third quarter of last year.

Reported operating profit for the nine-month period was $168m, versus a loss of $147m the year before, while Q3 operating profit came in at $38m compared to $18m in the same period a year ago.

Indivior upgraded its full-year net revenue range to between $750m and $770m from previous guidance of $705m to $740m. It also increased its FY net revenue range for Sublocade to between $235m and $245m from $210m to $230m, based on stronger demand and progress in the US criminal justice system.

The group also said adjusted pre-tax income was set to be at a higher level than previous management expectations.

Chief executive officer Mark Crossley said: "We are pleased to report another quarter of good growth and further strengthening of our leadership in addiction treatment. Based on the strong commercial execution behind Sublocade (buprenorphine extended-release) injection and the resilience of our legacy US film business, we have again raised our 2021 net revenue expectations for the overall group and for Sublocade.

"Our strategy to focus on the large and growing opportunity in organized health systems (OHS) has seen us deliver five consecutive quarters of double-digit underlying net revenue growth for Sublocade, providing us strong momentum as we look forward to 2022."

[youngers] 28/10/2021 12:35

Looks good to me. Another strong quarter of growth. Full year guidance revised up again. Lower net profit in q3 but looks mostly due to higher investment into sales and marketing costs

[irnbru4] 28/10/2021 12:14

Time on webcast page says 28/10 1300.

[youngers] 28/10/2021 12:10

Where are the q3 results then. Due at 12

[gregmorg] 25/10/2021 13:28

Quite simply follow that link, or sign in direct via the indivior investors webpages. and pre register. Its easy and can be informative.

However, my experience is these things also can be quite tedious(especially the scientific bits) with the majority of participating analysts at the end , being the Q and A period, really testing ones propensity to remain awake! Doesn't stop me from registering for quite a number of these things though-- a real glutton for punishment!
Yet so far so good.

[waldron] 25/10/2021 13:16

ali click on this link

[ali47fish] 25/10/2021 13:07

does anyone has a link to the webcast - know how to access it please!

[ariane] 25/10/2021 11:55

October 28, 2021

Q3 2021 Results Webcast

Time: 1 pm BST (8 am EST)

[gregmorg] 25/10/2021 11:31

ah, nice to see . Admit to taking the ST but I somehow missed that article yesterday.
Many thanks. It explains the few pennies rise this AM. Let us see what Thursday figures and webcast brings

[waldron] 24/10/2021 17:58

Alexander Bueso

Sharecast News

24 Oct, 2021 17:32 24 Oct, 2021 17:32

Sunday share tips: Light Science Technologies, Indivior


The Financial Mail on Sunday's Midas column told readers to buy shares of Light Science Technologies, pointing out the benefits of the company's technology for health, climate and the UK more economy.



"The shares are 12.45p and should increase substantially in value as this country and others focus on producing more food closer to home," the tipster said.

At present only 23% of the fruits and vegetables consumer in the UK were produced in the country and roughly a fifth of the UK's greenhouse gas emissions were generated by the food industry.

Light Science's technology also allowed producers to raise yield, while improving both the taste and nutritional value of food.

The company has developed over 40 variations of lighting kit that are individually tailored to growers' needs for use in glasshouses and polytunnels as well as indoor farms.

It has also developed the sensors needed to monitor everything from oxygen and carbon dioxide to humidity and gentle breezes at certain stages.

Using the technology, farmers can grown crops year round, locally and boost their income, as many are forced to import fruit and veg at a loss in winter in order to fulfil supermarket contracts.

"Light Science Technology Holdings combines a robust, revenue-generating circuits business with an exciting new division, that operates in a fast-growing market and can help to solve some of the UK's knottiest food production issues," says the Financial Mail on Sunday's Midas column.

"As a relatively young firm, the outlook is not risk-free but, for investors keen to support entrepreneurial UK businesses, the shares, at 12.45p, are a buy."




The Sunday Times's Sabah Meddings tipped shares of Indivior to readers arguing that the drugmaker appeared to have completed its journey to redemption.

Two years after being charged with engaging in an "illicit nationwide scheme to increase prescriptions", the company was branching out into alcohol misuse drugs and had invested in a new treatment for cannabis-related disorders.

It was also successfully growing sales of its treatment for opioid addiction, Sublocade.

Hence, the shares' near 120% recovery year-to-date, she said.

Yet that remains at nearly only half the level at which they had been trading in 2018, before being struck with generic competition and a US indictment.

She also noted that its former finance chief, Mark Crossley, had taken over as chief executive officer in June,

That was on top of the appointment of Cindy Cetani, formerly of Novartis, as the company's chief integrity and compliance officer.

In a bid to rebuild confidence, it had also named four new board members.

Finally, the company wanted to reach sales of over $1bn with Sublocade and was planning to invest heavily in marketing Sublocade, including on a sales force to sell into the criminal justice system.

"Buy."

[ariane] 13/10/2021 09:12

Indivior : to Announce Q3 / 9 Months YTD 2021 Results and Host a Presentation on October 28th



10/12/2021 | 02:42pm BST

Indivior to Announce Q3 / 9 Months YTD 2021 Results and Host a Presentation on October 28th 12/10/2021

Slough, UK, and Richmond, VA, October 12, 2021 - Indivior PLC (LON: INDV) today announced that it will release its Q3 / 9 months YTD 2021 results on October 28th at 12:00 London time (7:00 a.m. U.S. Eastern). The results will be available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at www.indivior.com.

Mark Crossley, Chief Executive Officer, and other members of Indivior's leadership team will host a conference call presentation via a live webcast at 13:00 London time (8:00 a.m. U.S. Eastern) on October 28th.

Access to the Live Webcast Presentation

The webcast event and materials can be accessed on the "Investors" section of the company's website at www.indivior.com before the event begins.

The webcast link is: hxxps://edge.media-server.com/mmc/p/oy28w6i3.

Participants may access the presentation telephonically:

US participants 1-646-741-3167
International participants [phone]
Please reference confirmation ID 6677702. A replay of the presentation will be available at www.indivior.com.

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease.

Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 700 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.comto learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

[ariane] 13/10/2021 09:10

[United Kingdom] INDIVIOR PLC (INDV)

Real-time Estimate Quote. Real-time Estimate Cboe Europe - 10/13 09:06:14 am

223.2 GBX +0.09%

[waldron] 13/10/2021 05:44

European markets head for subdued open amid jitters over growth, inflation

Published Wed, Oct 13 202112:33 AM EDT

Holly Ellyatt
@HollyEllyatt
cnbc

Key Points

European stocks are expected to open slightly lower on Wednesday as concerns around global growth and inflation continue to rattle market sentiment.

The U.K.’s FTSE index is seen opening 14 points lower at 7,117, Germany’s DAX 3 points lower at 15,141, France’s CAC 40 down 2 points at 6,541 and Italy’s FTSE MIB 43 points lower at 25,621, according to data from IG.

[blueclyde] 12/10/2021 21:23

Through 220. Volume appears to have dried up meaning that any sellers should now be out. Hard to see how it does not drift it up here to 300p? I decent set of results at the end of the month to look forward too?

[waldron] 12/10/2021 06:33

Published Tue, Oct 12 202112:17 AM EDT

Updated 60 Min Ago

Holly Ellyatt
@HollyEllyatt
CNBC

Key Points

European stocks are expected to open in negative territory on Tuesday amid widespread gloomy sentiment in global markets.

The U.K.’s FTSE index is seen opening 43 points lower at 7,094, Germany’s DAX 99 points lower at 15,085, France’s CAC 40 down 51 points at 6,514 and Italy’s FTSE MIB 203 points lower at 25,426, according to IG data.

[youngers] 11/10/2021 13:59

Trying and failing to get through 220p every day. Will hopefully blow higher once it clears this hurdle

[waldron] 08/10/2021 10:49

[United Kingdom] INDIVIOR PLC (INDV)

Real-time Estimate Quote. Real-time Estimate Cboe Europe - 10/08 10:45:18 am

219.2 GBX +1.76%

Might well do so as apparently broken thru the strong resistence at 218p

enjoy yer day and weekend

[youngers] 08/10/2021 10:28

Having another run at that 220p resistance this morning

[waldron] 08/10/2021 06:37

TRANSACTIONS IN OWN SHARES

October 7, 2021

INDIVIOR PLC ("Indivior") announces that on October 6, 2021 it purchased for cancellation the following number of its ordinary shares of $0.10 each through Morgan Stanley & Co. International Plc.

Ordinary Shares


Date of purchases: October 6, 2021
Number of ordinary shares purchased: 342,225
Highest Price per share: 216.00
Lowest Price per share: 208.60
Volume Weighted Average Price per day per trading
venue: 212.09


Indivior intends to cancel all of the purchased shares.



FOREVER UP AND TO BE CONTINUED

[waldron] 30/9/2021 19:50

THE WISH LIST GIVING BOXES,Supports and Resistences to determine channels and trends together with broker targets which might of course make you smile or and smirk


140 to 150p
150 to 160p
160 to 170p
170 to 180p
180 to 190p
190 to 200p
200 to 220p$$$$$$$$$$$$ WE ARE HERE $$$$$$$$$$$$$$$
220 to 240pJefferies target 220p



DECEMBER END 2019 GIVES 39p

December 2020 ends at 108.80p

January 2021 ends at 137.35p

February 2021 ends at 128.10p

March 2021 ends at 127.10p

April 2021 ends at 152.60p

May 2021 ends at 156.40p

June 2021 ends at 155.80p

July 2021 ends at 165p

August 2021 wnds at 194.40p

September 2021 wnds at 215.80p






INVVY ADR USD EQUAL TO 5 INDV SHARES



Upcoming events on INDIVIOR PLC

November/04/2021 Q3 2021 Earnings Release (Projected)

[waldron] 30/9/2021 19:47

Price (GBX)
215.80 0.84% (1.80)

Open / Last close
- / 215.80

High / Low
220.00 / 215.60

Bid / Offer
216.00 / 216.40

Special Condition: -

Trading Status: Market Close

FTSE 250

As at 30.09.21 19:30:19 - All data delayed at least 15 minutes